An interesting identified target was serum/glucocorticoid-regulated kinase 2 (SGK2), which was downregulated in MVID patient enteroids relative to healthy controls, but significantly upregulated upon DAPT treatment. This evidence concerns the gene SGK2 and microvillus inclusion disease.